Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology
О. Н. Ткачева(Pirogov Russian National Research Medical University), Г. А. Чумакова(Russian Society of Cardiology), S. V. Villevalde, Yа. A. Orlova, Е В Фролова(Pirogov Russian National Research Medical University), Е. И. Баранова, Н. К. Рунихина, В. С. Остапенко(Pirogov Russian National Research Medical University), Nana Pogosova(National Medical Research Center of Cardiology), А. О. Конради(Federal Almazov North-West Medical Research Centre), С. В. Булгакова(City Clinical Hospital), D. V. Duplyakov(Samara State Medical University), Н. В. Шарашкина(Pirogov Russian National Research Medical University), К. И. Прощаев, Ж. Д. Кобалава, С. В. Недогода, A N Ilnitskiy, O. A. Кislyak
Cited by 9
Related Papers
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis
|BMC Medicine|2016|904
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
|The Lancet|2019|640
The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future
|Connected Health|2022|373
Disorders of lipid metabolism. Clinical Guidelines 2023
|Russian Journal of Cardiology|2023|195